Bertrand L. Chenard

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Stefan Just, Bertrand L. Chenard, Angelo Ceci et al. · PLoS ONE · 2018 · 135 citations · Full text

CP-101,606, a potent neuroprotectant selective for forebrain neurons

Frank S. Menniti, Bertrand L. Chenard, Mary Collins et al. · European Journal of Pharmacology · 1997 · 111 citations

Forebrain Neurons, Neurotransmitter, Neuropharmacology +6

.alpha.-Nitroarylation of ketones and esters: an exceptionally facile synthesis of indoles, 2-indolinones and arylacetic acids

T. V. RajanBabu, Bertrand L. Chenard, Michael A. Petti · The Journal of Organic Chemistry · 1986 · 85 citations

Arylacetic Acidst, Biosynthesis, Engineering +12

Transient receptor potential ion channels as targets for the discovery of pain therapeutics.

James E. Krause, Bertrand L. Chenard, Daniel N. Cortright · PubMed · 2005 · 59 citations

Acute Pain, Pain Medicine, Trpv1 Antagonists +22

CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents

Frank S. Menniti, Martin J. Pagnozzi, Paul Butler et al. · Neuropharmacology · 2000 · 56 citations

Medicine, Neuropharmacology, Neuroscience +4